Ocular melanoma, a rare yet formidable cancer, originates in the melanocytes of the eye, specifically within the uvea—a crucial layer encompassing the iris, ciliary body, and choroid. These melanocytes, responsible for pigment production, undergo malignant transformation, leading to potential symptoms like vision blurring, light flashes, or dark spots on the iris.
Diagnosis typically involves a thorough eye examination supplemented by imaging techniques such as ultrasound or MRI scans. Treatment strategies vary based on tumor size and location, ranging from surgical interventions and radiation therapy to, in severe cases, enucleation (eye removal). Early detection through regular eye check-ups remains pivotal for optimizing treatment efficacy and patient outcomes in managing this challenging condition.







Title : Why a paediatric orthoptic oncology service matters
Shenika Tailor, University Hospitals of Leicester NHS Trust, United Kingdom
Title : Stereotactic radiotherapy for wet age-related macular degeneration: year 4 results of a randomised, double-masked, sham-controlled trial
Tim Jackson, King’s College London, United Kingdom